• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PA28γ:古老蛋白酶体激活剂的新见解。

PA28γ: New Insights on an Ancient Proteasome Activator.

机构信息

Department of Veterinary Sciences, University of Turin, Largo P. Braccini 2, 10095 Grugliasco, Italy.

出版信息

Biomolecules. 2021 Feb 5;11(2):228. doi: 10.3390/biom11020228.

DOI:10.3390/biom11020228
PMID:33562807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7915322/
Abstract

PA28 (also known as 11S, REG or PSME) is a family of proteasome regulators whose members are widely present in many of the eukaryotic supergroups. In jawed vertebrates they are represented by three paralogs, PA28α, PA28β, and PA28γ, which assemble as heptameric hetero (PA28αβ) or homo (PA28γ) rings on one or both extremities of the 20S proteasome cylindrical structure. While they share high sequence and structural similarities, the three isoforms significantly differ in terms of their biochemical and biological properties. In fact, PA28α and PA28β seem to have appeared more recently and to have evolved very rapidly to perform new functions that are specifically aimed at optimizing the process of MHC class I antigen presentation. In line with this, PA28αβ favors release of peptide products by proteasomes and is particularly suited to support adaptive immune responses without, however, affecting hydrolysis rates of protein substrates. On the contrary, PA28γ seems to be a slow-evolving gene that is most similar to the common ancestor of the PA28 activators family, and very likely retains its original functions. Notably, PA28γ has a prevalent nuclear localization and is involved in the regulation of several essential cellular processes including cell growth and proliferation, apoptosis, chromatin structure and organization, and response to DNA damage. In striking contrast with the activity of PA28αβ, most of these diverse biological functions of PA28γ seem to depend on its ability to markedly enhance degradation rates of regulatory protein by 20S proteasome. The present review will focus on the molecular mechanisms and biochemical properties of PA28γ, which are likely to account for its various and complex biological functions and highlight the common features with the PA28αβ paralog.

摘要

PA28(也称为 11S、REG 或 PSME)是一种蛋白酶体调节因子家族,其成员广泛存在于许多真核超类群中。在有颚脊椎动物中,它们由三个同源物 PA28α、PA28β 和 PA28γ 组成,这些同源物组装成七聚体异源(PA28αβ)或同源(PA28γ)环,位于 20S 蛋白酶体圆柱形结构的一个或两个末端。虽然它们具有高度的序列和结构相似性,但这三种同工型在生化和生物学特性方面有很大的不同。事实上,PA28α 和 PA28β 似乎出现得更晚,进化得更快,以执行专门针对 MHC I 类抗原呈递过程的新功能。与之相符的是,PA28αβ 有利于蛋白酶体释放肽产物,特别适合支持适应性免疫反应,而不影响蛋白质底物的水解速率。相反,PA28γ 似乎是一个进化缓慢的基因,与 PA28 激活剂家族的共同祖先最为相似,很可能保留了其原始功能。值得注意的是,PA28γ 主要定位于核内,参与调节包括细胞生长和增殖、细胞凋亡、染色质结构和组织以及对 DNA 损伤的反应等多种重要的细胞过程。与 PA28αβ 的活性形成鲜明对比的是,PA28γ 的大多数这些不同的生物学功能似乎依赖于其明显增强 20S 蛋白酶体对调节蛋白降解速率的能力。本综述将重点介绍 PA28γ 的分子机制和生化特性,这些特性可能解释了其复杂多样的生物学功能,并突出了与 PA28αβ 同源物的共同特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/23050f2bcd22/biomolecules-11-00228-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/5d4ef906e1e7/biomolecules-11-00228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/5437b5c63756/biomolecules-11-00228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/7d2f68e1ecf7/biomolecules-11-00228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/23050f2bcd22/biomolecules-11-00228-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/5d4ef906e1e7/biomolecules-11-00228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/5437b5c63756/biomolecules-11-00228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/7d2f68e1ecf7/biomolecules-11-00228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870a/7915322/23050f2bcd22/biomolecules-11-00228-g004.jpg

相似文献

1
PA28γ: New Insights on an Ancient Proteasome Activator.PA28γ:古老蛋白酶体激活剂的新见解。
Biomolecules. 2021 Feb 5;11(2):228. doi: 10.3390/biom11020228.
2
Atomic resolution Cryo-EM structure of human proteasome activator PA28γ.人蛋白酶体激活因子 PA28γ 的原子分辨率冷冻电镜结构。
Int J Biol Macromol. 2022 Oct 31;219:500-507. doi: 10.1016/j.ijbiomac.2022.07.246. Epub 2022 Aug 4.
3
PA28γ-20S proteasome is a proteolytic complex committed to degrade unfolded proteins.PA28γ-20S 蛋白酶体是一种负责降解未折叠蛋白质的蛋白水解复合物。
Cell Mol Life Sci. 2021 Dec 16;79(1):45. doi: 10.1007/s00018-021-04045-9.
4
Differential roles of proteasome and immunoproteasome regulators Pa28αβ, Pa28γ and Pa200 in the degradation of oxidized proteins.蛋白酶体和免疫蛋白酶体调节因子 Pa28αβ、Pa28γ 和 Pa200 在氧化蛋白降解中的差异作用。
Arch Biochem Biophys. 2012 Jul 15;523(2):181-90. doi: 10.1016/j.abb.2012.04.018. Epub 2012 Apr 30.
5
PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.PIP30/FAM192A 是核蛋白酶体激活物 PA28γ 的新型调节因子。
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6477-E6486. doi: 10.1073/pnas.1722299115. Epub 2018 Jun 22.
6
Proteasome activator 28γ (PA28γ) allosterically activates trypsin-like proteolysis by binding to the α-ring of the 20S proteasome.蛋白酶体激活因子 28γ(PA28γ)通过与 20S 蛋白酶体的α环结合,变构激活胰凝乳蛋白酶样蛋白水解。
J Biol Chem. 2022 Aug;298(8):102140. doi: 10.1016/j.jbc.2022.102140. Epub 2022 Jun 14.
7
A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking.PA28γ蛋白酶体在核斑点组织和SR蛋白运输中的新作用。
Mol Biol Cell. 2008 Apr;19(4):1706-16. doi: 10.1091/mbc.e07-07-0637. Epub 2008 Feb 6.
8
PA28γ, the ring that makes tumors invisible to the immune system?PA28γ,使肿瘤躲过免疫系统的“指环”?
Biochimie. 2024 Nov;226:136-147. doi: 10.1016/j.biochi.2024.04.003. Epub 2024 Apr 16.
9
PA28αβ overexpression enhances learning and memory of female mice without inducing 20S proteasome activity.PA28αβ过表达增强雌性小鼠的学习和记忆能力,且不诱导20S蛋白酶体活性。
BMC Neurosci. 2018 Nov 6;19(1):70. doi: 10.1186/s12868-018-0468-2.
10
Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.蛋白酶体活性的抑制诱导替代蛋白酶体复合物的形成。
J Biol Chem. 2016 Jun 17;291(25):13147-59. doi: 10.1074/jbc.M116.717652. Epub 2016 Apr 18.

引用本文的文献

1
Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis.不仅仅是PA28γ:我们对PA28αβ在致癌作用中的作用的了解。
Biomolecules. 2025 Jun 16;15(6):880. doi: 10.3390/biom15060880.
2
PSME3 regulates migration and differentiation of myoblasts.蛋白酶体激活因子3(PSME3)调节成肌细胞的迁移和分化。
Life Sci Alliance. 2025 Jun 19;8(9). doi: 10.26508/lsa.202503208. Print 2025 Sep.
3
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。

本文引用的文献

1
PA28γ-20S proteasome is a proteolytic complex committed to degrade unfolded proteins.PA28γ-20S 蛋白酶体是一种负责降解未折叠蛋白质的蛋白水解复合物。
Cell Mol Life Sci. 2021 Dec 16;79(1):45. doi: 10.1007/s00018-021-04045-9.
2
Cryo-EM of mammalian PA28αβ-iCP immunoproteasome reveals a distinct mechanism of proteasome activation by PA28αβ.哺乳动物 PA28αβ-iCP 免疫蛋白酶体的冷冻电镜显示了 PA28αβ 激活蛋白酶体的独特机制。
Nat Commun. 2021 Feb 2;12(1):739. doi: 10.1038/s41467-021-21028-3.
3
Molecular and cellular dynamics of the 26S proteasome.
J Cell Sci. 2025 May 15;138(10). doi: 10.1242/jcs.263887. Epub 2025 May 23.
4
Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS-mutant cancer models.用小分子靶向非泛素依赖性蛋白酶体可增加泛KRAS突变癌症模型的易感性。
J Clin Invest. 2025 Mar 17;135(6):e185278. doi: 10.1172/JCI185278.
5
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
6
Tracking proteasome degradation: A cross-organ analysis via intact degradomics mass spectrometry.追踪蛋白酶体降解:通过完整降解组学质谱法进行的跨器官分析。
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2419607122. doi: 10.1073/pnas.2419607122. Epub 2025 Feb 18.
7
Molecular insights into the unique properties of the blood-circulating proteasome.对血液循环蛋白酶体独特性质的分子见解。
J Extracell Biol. 2025 Jan 27;4(1):e70034. doi: 10.1002/jex2.70034. eCollection 2025 Jan.
8
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
bioRxiv. 2025 Jan 15:2025.01.15.633194. doi: 10.1101/2025.01.15.633194.
9
Inhibition of PA28γ expression can alleviate osteoarthritis by inhibiting endoplasmic reticulum stress and promoting STAT3 phosphorylation.抑制PA28γ的表达可通过抑制内质网应激和促进STAT3磷酸化来减轻骨关节炎。
Bone Joint Res. 2024 Nov 20;13(11):659-672. doi: 10.1302/2046-3758.1311.BJR-2023-0361.R2.
10
Limiting 20S proteasome assembly leads to unbalanced nucleo-cytoplasmic distribution of 26S/30S proteasomes and chronic proteotoxicity.限制20S蛋白酶体组装会导致26S/30S蛋白酶体在核质分布失衡以及慢性蛋白毒性。
iScience. 2024 Oct 4;27(11):111095. doi: 10.1016/j.isci.2024.111095. eCollection 2024 Nov 15.
26S 蛋白酶体的分子和细胞动力学。
Biochim Biophys Acta Proteins Proteom. 2021 Mar;1869(3):140583. doi: 10.1016/j.bbapap.2020.140583. Epub 2020 Dec 13.
4
Mechanisms of substrate recognition by the 26S proteasome.26S 蛋白酶体的底物识别机制。
Curr Opin Struct Biol. 2021 Apr;67:161-169. doi: 10.1016/j.sbi.2020.10.010. Epub 2020 Dec 6.
5
Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks.人类 20S 蛋白酶体的构象图谱揭示了 PA28-和免疫依赖性的环间串扰。
Nat Commun. 2020 Dec 1;11(1):6140. doi: 10.1038/s41467-020-19934-z.
6
Structure, Dynamics and Function of the 26S Proteasome.26S 蛋白酶体的结构、动态与功能。
Subcell Biochem. 2021;96:1-151. doi: 10.1007/978-3-030-58971-4_1.
7
PA28γ, an Accomplice to Malignant Cancer.PA28γ,恶性肿瘤的帮凶。
Front Oncol. 2020 Oct 30;10:584778. doi: 10.3389/fonc.2020.584778. eCollection 2020.
8
Role of oncogenic REGγ in cancer.致癌基因 REGγ 在癌症中的作用。
Biomed Pharmacother. 2020 Oct;130:110614. doi: 10.1016/j.biopha.2020.110614. Epub 2020 Aug 14.
9
Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3.肿瘤通过过表达蛋白酶体激活剂 PSME3 来逃避免疫监视。
Oncoimmunology. 2020 May 21;9(1):1761205. doi: 10.1080/2162402X.2020.1761205.
10
Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.蛋白酶体激活剂 PA28γ 依赖的冠状病毒病(COVID-19)核衣壳蛋白降解。
Biochem Biophys Res Commun. 2020 Aug 20;529(2):251-256. doi: 10.1016/j.bbrc.2020.06.058. Epub 2020 Jun 16.